Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,116
Total Claims
$697K
Drug Cost
485
Beneficiaries
$1,437
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-36%
Opioid rate vs peers
1.4% vs 2.2% avg
+2%
Cost per patient vs peers
$1,437 vs $1,411 avg
+18%
Brand preference vs peers
12.5% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.4%
Opioid Rate
131
Opioid Claims
$1,094
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,132 claims · $589K
Generic: 7,906 claims · $104K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 232 | $141K |
| Rivaroxaban | 165 | $120K |
| Sacubitril/Valsartan | 48 | $64K |
| Empagliflozin | 57 | $48K |
| Sitagliptin Phosphate | 32 | $36K |
| Insulin Glargine,hum.Rec.Anlog | 25 | $19K |
| Fluticasone/Vilanterol | 29 | $18K |
| Semaglutide | 12 | $12K |
| Insulin Detemir | 12 | $8,026 |
| Insulin Glargine,hum.Rec.Anlog | 26 | $7,948 |
| Fluticasone/Umeclidin/Vilanter | 11 | $7,247 |
| Insulin Detemir | 12 | $6,557 |
| Pantoprazole Sodium | 443 | $5,230 |
| Potassium Chloride | 230 | $5,090 |
| Metoprolol Succinate | 292 | $4,772 |
Prescribing Profile
Patient Profile
78
Avg Age
59%
Female
1.54
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About